Vistin Pharma ASA (LON:0RAM)

Vistin Pharma ASA Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 23, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	73	74	80	59	72	66
Market Cap Growth	-1.90%	-7.63%	35.53%	-18.07%	8.95%	66.93%
Enterprise Value	74	74	80	62	68	58
Last Close Price	1.60	1.63	1.61	1.07	1.55	1.26
PE Ratio	12.51	16.75	22.66	-	34.56	-
PS Ratio	2.14	2.45	2.36	2.30	3.08	3.05
PB Ratio	3.12	3.40	3.20	2.56	3.12	2.84
P/TBV Ratio	3.12	3.40	3.20	2.56	3.12	2.84
P/FCF Ratio	15.04	15.67	14.21	-	-	-
P/OCF Ratio	12.25	9.74	11.41	-	62.82	-
EV/Sales Ratio	2.12	2.45	2.36	2.43	2.90	2.67
EV/EBITDA Ratio	8.29	10.20	12.19	138.71	18.91	12.49
EV/EBIT Ratio	10.18	12.35	15.08	-	24.34	14.89
EV/FCF Ratio	15.35	15.71	14.23	-	-	-
Debt / Equity Ratio	0.07	0.00	-	0.18	0.01	-
Debt / EBITDA Ratio	0.20	0.01	-	7.95	0.03	-
Debt / FCF Ratio	0.35	0.02	-	-	-	-
Net Debt / Equity Ratio	0.06	-0.04	-0.08	0.18	-0.12	-0.28
Net Debt / EBITDA Ratio	0.17	-0.11	-0.31	8.95	-0.80	-1.42
Net Debt / FCF Ratio	0.30	-0.17	-0.36	-0.64	1.88	0.39
Asset Turnover	1.12	1.09	1.08	0.82	0.85	0.62
Inventory Turnover	1.87	1.91	2.16	2.19	2.57	2.62
Quick Ratio	1.16	1.01	1.24	0.62	1.92	3.38
Current Ratio	2.23	2.24	2.43	1.35	3.36	4.39
Return on Equity (ROE)	25.04%	19.85%	15.29%	-1.72%	9.07%	-28.27%
Return on Assets (ROA)	14.56%	13.53%	10.58%	-1.03%	6.35%	6.89%
Return on Invested Capital (ROIC)	20.68%	22.33%	17.30%	-2.17%	11.79%	31.24%
Return on Capital Employed (ROCE)	27.80%	26.60%	20.50%	-2.10%	11.40%	15.70%
Earnings Yield	7.99%	5.97%	4.41%	-0.67%	2.89%	-12.53%
FCF Yield	6.65%	6.38%	7.03%	-10.68%	-2.13%	-25.70%
Dividend Yield	0.43%	5.39%	4.80%	5.93%	4.07%	3.38%
Payout Ratio	69.56%	123.65%	-	-	89.17%	-
Total Shareholder Return	0.43%	5.39%	4.80%	5.93%	4.07%	3.38%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.